
IREN, American Airlines Group, and CG Oncology are the three Mid Cap stocks to watch today, according to MarketBeat’s stock screener tool. Mid-cap stocks are shares of companies with a medium-sized market capitalization, typically between about $2 billion and $10 billion, though the exact range varies by index or provider. Investors often view them as offering more growth potential than large-cap stocks, while generally carrying less risk than small-cap stocks. These companies had the highest dollar trading volume of any Mid Cap stocks within the last several days.
IREN (IREN)
IREN Limited, formerly known as Iris Energy Limited, owns and operates bitcoin mining data centers. The company was incorporated in 2018 and is headquartered in Sydney, Australia.
IREN traded down $1.64 during mid-day trading on Monday, reaching $16.53. 58,356,542 shares of the stock were exchanged, compared to its average volume of 45,392,840. The company has a debt-to-equity ratio of 1.77, a quick ratio of 1.60 and a current ratio of 1.60. The stock has a market capitalization of $7.01 billion, a PE ratio of -4.06 and a beta of 4.33. The company has a 50 day moving average price of $34.05 and a two-hundred day moving average price of $42.73. IREN has a 1 year low of $16.01 and a 1 year high of $70.71.
Read Our Latest Research Report on IREN
American Airlines Group (AAL)
American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo.
Shares of AAL traded up $0.03 during trading hours on Monday, reaching $13.20. 44,414,972 shares of the stock traded hands, compared to its average volume of 76,248,867. The stock has a fifty day simple moving average of $12.94 and a 200 day simple moving average of $13.49. American Airlines Group has a 52 week low of $10.09 and a 52 week high of $18.79. The company has a market cap of $8.75 billion, a price-to-earnings ratio of -18.05 and a beta of 1.45.
Read Our Latest Research Report on AAL
CG Oncology (CGON)
CG Oncology, Inc., an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients.
CGON stock traded up $11.45 during trading on Monday, reaching $85.84. The stock had a trading volume of 6,797,376 shares, compared to its average volume of 1,129,252. The company has a market capitalization of $7.67 billion, a price-to-earnings ratio of -31.30 and a beta of 0.35. CG Oncology has a one year low of $37.01 and a one year high of $93.95. The company’s 50 day moving average is $68.04 and its two-hundred day moving average is $66.54.
Read Our Latest Research Report on CGON
Further Reading
- MarketBeat’s Top Five Stocks to Own in November 2026
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
